Effectiveness of expanding annual mass azithromycin distribution treatment coverage for trachoma in Niger: A cluster randomized trial

BACKGROUND/AIMS: The World Health Organization recommends 3–5 years of annual mass azithromycin distribution with at least 80% treatment coverage to districts with active trachoma prevalence over 10% among children. Here, we assess the efficacy of expanding the coverage target to at least 90% for tr...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Br J Ophthalmol
Asıl Yazarlar: Amza, Abdou, Kadri, Boubacar, Nassirou, Beido, Cotter, Sun Y., Stoller, Nicole E., West, Sheila K., Bailey, Robin L., Porco, Travis C., Gaynor, Bruce D., Keenan, Jeremy D., Lietman, Thomas M., Oldenburg, Catherine E.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2017
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5845832/
https://ncbi.nlm.nih.gov/pubmed/28893761
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bjophthalmol-2017-310916
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller